Skip to main content

Urban Jungle posts £6.2m loss for 2024

Jimmy Williams

Urban Jungle has reported a £6.2m loss for the year ending 30 September 2024.

A Companies House filing published on 1 July showed a slight reduction from its £7.2m loss in 2023, and the gross profit in 2024 was £4.6m, a 35% increase on 2023’s £3.4m.

The report from CEO Jimmy

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

Show password
Hide password

Q&A: Chris Methven, CyberCube

Chris Methven, the new CEO of CyberCube, reveals how fresh financial backing will allow his business to place bigger, longer-term bets on global expansion, deeper analytics and new capabilities.

Big Interview: Dan McNally, Tide

Dan McNally, SVP and CEO of Tide Insurance Services, tells Insurance Post what drew him to lead the business management platform’s foray into insurance and how he intends to make an impact in the market.

ChatGPT insurance race: UK’s Malcolm takes on WaniWani

A UK insurtech incubated in Founders Factory is looking to take on US ChatGPT insurance app trailblazer WaniWani by creating an equivalent to Stripe’s standards for e-commerce “to properly unlock” artificial intelligence distribution in personal and SME commercial lines.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here